ProductLife Group (PLG), a global leader in consulting and outsourcing services for the Life Sciences industry, announces the release of its latest report titled “An Introduction to the Transformative Power of AI in Shaping the Pharmaceutical Industry.” The pharmaceutical sector is undergoing unprecedented technological acceleration, largely driven by artificial intelligence (AI). This report explores how AI is already transforming key areas such as regulatory affairs, manufacturing, pharmacovigilance, and market access, as well as its potential for the future of R&D. Technologies like machine learning and generative AI are already in play, speeding up drug discovery, regulatory dossier preparation, and safety data monitoring. However, challenges remain, particularly in terms of data management, adoption of this new technology by teams and development of business models that justify investments in AI.

With its global expertise in the Life Sciences industry and the integration of AI-driven solutions, ProductLife Group helps its clients enhance operational efficiency. The report emphasizes the need for companies to balance the rapid adoption of IA tools for immediate gains with deeper transformation to ensure long-term competitive advantage.

Read the full document here